Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilie Lukasova

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Mutation Research|February 11, 2010
Higher-order chromatin structure in DSB induction, repair and misrepairMartin Falk, Emilie Lukasova, Stanislav Kozubek
Biochimica Et Biophysica Acta|September 14, 2007
Chromatin dynamics during DSB repairMartin Falk, Emilie Lukasova, Barbora Gabrielova, et al.
Experimental Hematology|March 30, 2006
Epigenetic heterochromatin markers distinguish terminally differentiated leukocytes from incompletely differentiated leukemia cells in human bloodEvgenya Y Popova, David F Claxton, Emilie Lukasova, et al.
Cellular Signalling|January 17, 2012
The BRCA1 alternative splicing variant Δ14-15 with an in-frame deletion of part of the regulatory serine-containing domain (SCD) impairs the DNA repair capacity in MCF-7 cellsJan Sevcik, Martin Falk, Petra Kleiblova, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Mutation Research|February 11, 2010
Higher-order chromatin structure in DSB induction, repair and misrepairMartin Falk, Emilie Lukasova, Stanislav Kozubek
Biochimica Et Biophysica Acta|September 14, 2007
Chromatin dynamics during DSB repairMartin Falk, Emilie Lukasova, Barbora Gabrielova, et al.
Experimental Hematology|March 30, 2006
Epigenetic heterochromatin markers distinguish terminally differentiated leukocytes from incompletely differentiated leukemia cells in human bloodEvgenya Y Popova, David F Claxton, Emilie Lukasova, et al.
Cellular Signalling|January 17, 2012
The BRCA1 alternative splicing variant Δ14-15 with an in-frame deletion of part of the regulatory serine-containing domain (SCD) impairs the DNA repair capacity in MCF-7 cellsJan Sevcik, Martin Falk, Petra Kleiblova, et al.
Pageof 1